Thromboxane B2 is widely used in medical research to study platelet function and blood clotting mechanisms. It serves as a biomarker for assessing thromboxane A2 activity, which plays a critical role in thrombosis and hemostasis. In clinical settings, it helps evaluate the effectiveness of antiplatelet therapies, such as aspirin, in patients with cardiovascular diseases. Additionally, it aids in understanding inflammatory responses and vascular disorders, providing insights into conditions like atherosclerosis and myocardial infarction. Its measurement in biological samples contributes to diagnosing and monitoring diseases related to abnormal platelet activation.